Breaking News Instant updates and real-time market news.

2020-12-04 08:28:47 BCRX BioCryst $5.14 / +0.1 (+1.98%) 08:28 12/04/20 12/04 08:28 12/04/20 08:28	BioCryst receives on-time approval with 'clean' label, says Piper Sandler BioCryst's Orladeyo has been approved by the FDA and it is now the first oral therapy for hereditary angioedema patients who continue to have limited injectable options, Piper Sandler analyst Tyler Van Buren tells investors in a research note. The label "appears quite clean and exactly as expected" based on what was observed in the registrational trials, adds the analyst. He sees Orladeyo "very likely" being a $500M-plus global product and believes the $485,000 price will encourage broad use. Van Buren reiterates an Overweight rating on BioCryst with a $10 price target.	11 Dec 28 May
BCRX BioCryst $5.14 / +0.1 (+1.98%) 11/23/20 Evercore ISI BioCryst initiated with an Outperform at Evercore ISI 11/23/20 Evercore ISI BioCryst initiated with an Outperform at Evercore ISI 11/05/20 Piper Sandler Piper Sandler reiterates Overweight rating on BioCryst ahead of 'busy year-end' 09/30/20 Piper Sandler Piper says BioCryst's early high dose 9930 data 'impressive'

2020-12-04 08:28:47

BCRX

BioCryst

$5.14 / +0.1 (+1.98%)

08:28

12/04/20

12/04

08:28

12/04/20

08:28

BioCryst receives on-time approval with 'clean' label, says Piper Sandler

BioCryst's Orladeyo has been approved by the FDA and it is now the first oral therapy for hereditary angioedema patients who continue to have limited injectable options, Piper Sandler analyst Tyler Van Buren tells investors in a research note. The label "appears quite clean and exactly as expected" based on what was observed in the registrational trials, adds the analyst. He sees Orladeyo "very likely" being a $500M-plus global product and believes the $485,000 price will encourage broad use. Van Buren reiterates an Overweight rating on BioCryst with a $10 price target.

11
Dec

28
May

BCRX BioCryst

$5.14 / +0.1 (+1.98%)

11/23/20 Evercore ISI: BioCryst initiated with an Outperform at Evercore ISI

11/23/20 Evercore ISI: BioCryst initiated with an Outperform at Evercore ISI

11/05/20 Piper Sandler: Piper Sandler reiterates Overweight rating on BioCryst ahead of 'busy year-end'

09/30/20 Piper Sandler: Piper says BioCryst's early high dose 9930 data 'impressive'

TODAY'S FREE FLY STORIES

Hot Stocks	Dr. Reddy's terminates Avigan Trial Study conducted in Kuwait » 05:07 01/27/21 01/27 05:07 01/27/21 05:07 RDY Dr. Reddy's $68.60 / -0.7499 (-1.08%) , APLIF Appili Therapeutics $0.00 / + (+0.00%) Dr. Reddy's (RDY)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events RDY APLIF RDY Dr. Reddy's $68.60 / -0.7499 (-1.08%) 01/15/21 Dr. Reddy's receives approval to conduct Phase 3 trial for Sputnik V vaccine 01/11/21 Dr. Reddy's says DSMB recommends continuation of Phase 2 trial of Sputnik V 01/11/21 Dr. Reddy's announces launch of Febuxostat tablets in U.S. 12/22/20 Dr. Reddy's Canada files application for Reeqonos Tablets under interim order APLIF Appili Therapeutics $0.00 / + (+0.00%) 12/02/20 Appili Therapeutics doses first participant in Avigan trial 11/24/20 Appili Therapeutics gets clearance from Health Canada on Covid study 10/20/20 Appili Therapeutics enrolls, doses first cluster of patients in CONTROL trial RDY APLIF RDY Dr. Reddy's $68.60 / -0.7499 (-1.08%) 09/18/20 Investec Dr. Reddy's upgraded to Hold from Sell at Investec 09/03/20 Oppenheimer Opco 'more skeptical' on Amarin patent win after 20 minute court hearing 09/02/20 Goldman Sachs Oral arguments incrementally negative for Amarin, says Goldman Sachs 08/10/20 Oppenheimer Amarin Perform rating affirmed at Oppenheimer after FDA approves Vascepa generic APLIF Appili Therapeutics $0.00 / + (+0.00%) 09/02/20 Industrial Alliance Appili Therapeutics initiated with a Buy at Industrial Alliance RDY RDY Dr. Reddy's $68.60 / -0.7499 (-1.08%) 09/02/20 Amarin slides after Vascepa patent appeal hearing ends 01/29/21 Dr. Reddy's - RDY
Upgrade	Avantium upgraded to Hold from Reduce at Kepler Cheuvreux » 05:06 01/27/21 01/27 05:06 01/27/21 05:06 AVTXF Avantium $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Downgrade	EDF downgraded to Reduce from Add at AlphaValue » 05:05 01/27/21 01/27 05:05 01/27/21 05:05 ECIFY EDF $0.00 / + (+0.00%) AlphaValue downgraded EDF… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ECIFY EDF $0.00 / + (+0.00%) 01/12/21 Kepler Cheuvreux EDF upgraded to Buy from Hold at Kepler Cheuvreux 01/07/21 JPMorgan EDF price target raised to EUR 18.50 from EUR 15.50 at JPMorgan 12/03/20 Bernstein EDF upgraded to Outperform from Market Perform at Bernstein 12/02/20 Barclays EDF price target raised to EUR 16 from EUR 12.50 at Barclays
Initiation	Safehold initiated with a Buy at Goldman Sachs » 04:59 01/27/21 01/27 04:59 01/27/21 04:59 SAFE Safehold $77.29 / -0.45 (-0.58%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate SAFE Safehold $77.29 / -0.45 (-0.58%) 11/12/20 Mizuho Safehold price target raised to $75 from $70 at Mizuho 10/23/20 Mizuho Safehold price target raised to $70 from $56 at Mizuho 07/27/20 Mizuho Safehold upgraded to Buy from Neutral at Mizuho 07/27/20 Mizuho Safehold upgraded to Buy from Neutral at Mizuho SAFE Safehold $77.29 / -0.45 (-0.58%) 10/22/20 Safehold reports Q3 EPS 28c, consensus 28c 11 Nov 18 Mar
Recommendations	Benefitfocus price target lowered to $20 from $29 at Piper Sandler » 04:57 01/27/21 01/27 04:57 01/27/21 04:57 BNFT Benefitfocus $13.49 / -0.41 (-2.95%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BNFT Benefitfocus $13.49 / -0.41 (-2.95%) 11/02/20 Benefitfocus appoints John Thomas as Chief Data Officer 09/08/20 Benefitfocus appoints Robin Kirby as Chief Human Resources Officer 08/24/20 Benefitfocus CEO Raymond August steps down, Stephen Swad succeeds BNFT Benefitfocus $13.49 / -0.41 (-2.95%) 01/25/21 Raymond James Benefitfocus did not bid on South Carolina contract, says Raymond James 01/25/21 Raymond James South Carolina award 'a lost opportunity' for Benefitfocus, says Raymond James 01/21/21 Raymond James Benefitfocus downgraded at Raymond James on 'aggressive' consensus estimates 01/21/21 Raymond James Benefitfocus downgraded to Market Perform from Outperform at Raymond James BNFT Benefitfocus $13.49 / -0.41 (-2.95%) 08/24/20 Benefitfocus backs FY20 EPS view (59c)-(44c), consensus (49c) 08/24/20 Benefitfocus backs Q3 EPS view (21c)-(12c), consensus (14c) 08/05/20 Benefitfocus sees FY20 EPS (59c)-(44c), consensus (50c) 08/05/20 Benefitfocus sees Q3 EPS (21c)-(12c), consensus (17c)

Downgrade	Aurizon downgraded to Sell from Buy at Goldman Sachs » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 QRNNF Aurizon $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research QRNNF Aurizon $0.00 / + (+0.00%) 03/31/20 Goldman Sachs Aurizon upgraded to Buy from Sell at Goldman Sachs
General news	January Fed Chair Press Conference to be released at 14:30 04:55 01/27/21 01/27 04:55 01/27/21 04:55
Conference/Events	Ardelyx participates in a conference call with Cantor Fitzgerald » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 ARDX Ardelyx $7.33 / -0.36 (-4.68%) Biopharma Analyst Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ARDX Ardelyx $7.33 / -0.36 (-4.68%) 09/15/20 Ardelyx annonces FDA accepted NDA of Tenapanor ARDX Ardelyx $7.33 / -0.36 (-4.68%) 01/21/21 Piper Sandler Ardelyx remains a top pick into April PDUFA at Piper Sandler 01/05/21 Cantor Fitzgerald Ardelyx initiated with an Overweight at Cantor Fitzgerald 12/11/20 SVB Leerink Ardelyx price target raised to $14 from $11 at SVB Leerink 10/20/20 Citi Ardelyx transferred with Buy rating, $13 target at Citi ARDX Ardelyx $7.33 / -0.36 (-4.68%) 11/05/20 Ardelyx reports Q3 EPS (20c), consensus (28c) 08/06/20 Ardelyx reports Q2 EPS (28c), consensus (26c) ARDX Ardelyx $7.33 / -0.36 (-4.68%) 01/06/21 Fly Intel: Pre-market Movers 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday 03/01/21 41st Annual Healthcare Virtual Conference 11:00 Today Ardelyx - ARDX 04/29/21 PDUFA Date
Conference/Events	Midwest Energy Emissions to host conference call » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 MEEC Midwest Energy Emissions $0.00 / + (+0.00%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Events MEEC Midwest Energy Emissions $0.00 / + (+0.00%) 01/19/21 Midwest Energy Emissions reaches license agreement with North American utility 01/11/21 Midwest Energy Emissions announces agreement with major national utility 12/01/20 Midwest Energy Emissions, AEP sign agreement for non-exclusive license 10/19/20 Midwest Energy Emissions engages MZ Group to lead investor relations MEEC Midwest Energy Emissions $0.00 / + (+0.00%) 11/24/20 Midwest Energy Emissions reports Q3 EPS (1c) vs. (1c) last year 11:30 Today Midwest Energy Emissions - MEEC
Conference/Events	Akebia management to meet virtually with Mizuho » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 AKBA Akebia $3.77 / +0.06 (+1.62%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 7 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options AKBA Akebia $3.77 / +0.06 (+1.62%) 11/16/20 Akebia reports manuscript on global Phase 3 INNO2VATE program rationale 10/23/20 Akebia down 1% to $3.24 after reporting additional data on vadadustat 10/23/20 Akebia trading resumes 10/23/20 Akebia CEO confident vadadustat has 'straightforward path to potential approval' AKBA Akebia $3.77 / +0.06 (+1.62%) 10/23/20 Piper Sandler Akebia rally justified as vadadustat has chance, says Piper Sandler 10/23/20 JPMorgan JPMorgan says Akebia's data 'do little' to restore confidence in NDD approval 09/04/20 RBC Capital Akebia price target lowered to $5 from $12 at RBC Capital 09/04/20 Stifel FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel AKBA Akebia $3.77 / +0.06 (+1.62%) 11/05/20 Akebia reports Q3 EPS (42c), consensus (17c) 08/10/20 Akebia reports Q2 EPS ($1.28), consensus (50c) 12 May AKBA Akebia $3.77 / +0.06 (+1.62%) 01/13/21 Researchers awarded funding to expand Akebia drug trial, UTHealth News says AKBA Akebia $3.77 / +0.06 (+1.62%) 09/03/20 Fly Intel: Wall Street's top stories for Thursday 09/03/20 Fly Intel: Wall Street's top stories at midday 09/03/20 Fly Intel: Pre-market Movers 08/10/20 Fly Intel: After-Hours Movers 00:00 Today Arcus Biosciences AKBA Akebia $3.77 / +0.06 (+1.62%) 10/12/20 Unusually active option classes on open October 12th

Conference/Events	Zymeworks to host conference call » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 ZYME Zymeworks $46.27 / -2.16 (-4.46%) Conference call to … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ZYME Zymeworks $46.27 / -2.16 (-4.46%) 01/15/21 Zymeworks announces new, updated zanidatamab data at ASCO 12/01/20 Zymeworks expands zanidatamab trial in HER2 in amplified biliary tract cancer 11/30/20 Zymeworks gets FDA breakthrough therapy designation for zanidatamab 11/19/20 Zymeworks receives orphan drug designation for zanidatamab ZYME Zymeworks $46.27 / -2.16 (-4.46%) 01/25/21 Citi Zymeworks downgraded to Neutral ahead of initial ZW49 data at Citi 01/25/21 Citi Zymeworks downgraded to Neutral from Buy at Citi 01/12/21 SVB Leerink Zymeworks price target raised to $66 from $45 at SVB Leerink 01/12/21 Wells Fargo Zymeworks price target raised to $71 from $58 at Wells Fargo ZYME Zymeworks $46.27 / -2.16 (-4.46%) 11/03/20 Zymeworks reports Q3 EPS ($1.43), consensus (67c) 08/05/20 Zymeworks reports Q2 EPS (77c), consensus (67c) 16:30 Today Zymeworks - ZYME
General news	Week of 1/22 MBA Mortgage Applications to be released at 07:00 04:55 01/27/21 01/27 04:55 01/27/21 04:55
General news	FOMC Announcement Federal Funds Rate to be reported at 14:00 » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 January FOMC Announcement… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial
Conference/Events	Barnes & Noble Education management to meet virtually with Craig Hallum » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 BNED Barnes & Noble Education $5.22 / -0.065 (-1.23%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BNED Barnes & Noble Education $5.22 / -0.065 (-1.23%) 12/29/20 Barnes & Noble Education rises 10.0% 12/29/20 Barnes & Noble Education rises 10.1% 12/21/20 Barnes & Noble Education enters merchandising partnership with Fanatics, Lids 10/12/20 Barnes & Noble College introduce custom-branded version of First Day Complete BNED Barnes & Noble Education $5.22 / -0.065 (-1.23%) 09/04/20 Fly Intel: Top five analyst upgrades 09/04/20 Craig-Hallum Barnes & Noble Education upgraded to Buy from Hold at Craig-Hallum 05/13/20 Needham CA schools online in fall negative for Barnes & Noble Education, says Needham 03/16/20 Craig-Hallum Barnes & Noble Education downgraded to Hold from Buy at Craig-Hallum BNED Barnes & Noble Education $5.22 / -0.065 (-1.23%) 12/08/20 Barnes & Noble Education reports Q2 EPS 15c, consensus (46c) 09/03/20 Barnes & Noble Education reports Q1 EPS (96c), two estimates (78c) BNED Barnes & Noble Education $5.22 / -0.065 (-1.23%) 12/29/20 Barnes & Noble Education CFO expects more cost cutting amid pandemic, WSJ says BNED Barnes & Noble Education $5.22 / -0.065 (-1.23%) 12/29/20 Fly Intel: Pre-market Movers 00:00 Today Barnes & Noble Education
Conference/Events	Earthstone Energy management to meet virtually with Roth Capital » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 ESTE Earthstone Energy $5.34 / -0.24 (-4.30%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ESTE Earthstone Energy $5.34 / -0.24 (-4.30%) 12/18/20 Earthstone Energy rises 14.8% 12/18/20 Earthstone Energy to acquire IRM for $185.9M in cash, shares 11/04/20 Earthstone Energy sees FY20 CapEx $65M-$70M 08/05/20 Earthstone Energy expects to average 13,000 - 14,000 Boepd for full year ESTE Earthstone Energy $5.34 / -0.24 (-4.30%) 01/04/21 Northland Earthstone Energy named a Top Pick for 2021 at Northland 12/16/20 Wells Fargo Wells Fargo says Buy Marathon Oil, Sell Berry Petroleum 12/16/20 Wells Fargo Earthstone Energy upgraded to Overweight from Equal Weight at Wells Fargo 09/02/20 Alliance Global Partners Earthstone Energy assumed with a Buy at Alliance Global Partners ESTE Earthstone Energy $5.34 / -0.24 (-4.30%) 11/04/20 Earthstone Energy reports Q3 adjusted EPS (18c), consensus 8c 08/05/20 Earthstone Energy reports Q2 adjusted EPS 20c, consensus 10c 03/15/21 33rd Annual Roth Virtual Conference 00:00 Today Earthstone Energy

Conference/Events	Romeo Power management to meet virtually with BTIG » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 RMO Romeo Power $20.16 / +1.66 (+8.97%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly Events Options RMO Romeo Power $20.16 / +1.66 (+8.97%) 01/13/21 Romeo Power rises 10.1% 01/04/21 HES, Romeo Power launch program to select fleet electrification partners 12/30/20 Romeo Power CEO calls current electrification rate forecasts 'really low' 12/29/20 Romeo Power and RMG Acquisition announce closing of business combination RMO Romeo Power $20.16 / +1.66 (+8.97%) 10/09/20 Workhorse seen as 'best fit' for $8.1B Post Office contract 00:00 Today Romeo Power RMO Romeo Power $20.16 / +1.66 (+8.97%) 12/30/20 Three new option listings and four option delistings on December 30th
Conference/Events	Aqua Metals hosts a conference call » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 AQMS Aqua Metals $7.21 / +1.32 (+22.41%) President & CEO… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events AQMS Aqua Metals $7.21 / +1.32 (+22.41%) 01/25/21 Aqua Metals, BASF establish global partnership 12/28/20 Aqua Metals completes V1.25L electrolyzer program on time, under budget 09/29/20 Aqua Metals receives additional $1.5M insurance payment 09/22/20 Aqua Metals announces intention to sell McCarran, Nevada plant AQMS Aqua Metals $7.21 / +1.32 (+22.41%) 03/12/20 Oppenheimer Aqua Metals price target lowered to $2 from $9 at Oppenheimer 14:00 Today Aqua Metals - AQMS
General news	Week of 1/22 MBA Mortgage Applications to be released at 07:00 04:55 01/27/21 01/27 04:55 01/27/21 04:55
Conference/Events	Newborn Acquisition Corp. management to meet virtually with Roth Capital » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 NBAC Newborn Acquisition Corp. $21.70 / +4.64 (+27.20%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Events NBAC Newborn Acquisition Corp. $21.70 / +4.64 (+27.20%) 12/16/20 Nuvve Corporation, IoTecha partner on EV charging solution 11/19/20 Nuvve, Lion Electric announce vehicle-to-grid collaboration 11/12/20 Newborn Acquisition Corp., Nuvve sign merger pact to take Nuvve public 00:00 Today Newborn Acquisition Corp.
Conference/Events	Truist leisure/lodging analysts hold an analyst/industry conference call » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 Lodging Analysts discuss… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

General news	Durable Goods Orders Ex-Transportation to be reported at 08:30 » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 December Durable Goods… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	TD Securities to hold a virtual conference » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 2021 Virtual Mining… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	The SEC to hold a committee meeting » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 Closed Commission Meeting… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 6 minutes Get Free Trial
General news	Week of 1/22 EIA Petroleum Status Report to be released at 10:30 04:55 01/27/21 01/27 04:55 01/27/21 04:55
Conference/Events	Stephens electrical equipment analyst holds analyst/industry conference call » 04:55 01/27/21 01/27 04:55 01/27/21 04:55 GNRC Generac $265.17 / -3.54 (-1.32%) Electrical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GNRC Generac $265.17 / -3.54 (-1.32%) 01/19/21 Generac Power Systems establishes Energy Technology organization 11/10/20 Generac and Milwaukee World Festival announce new partnership 11/03/20 Generac Chairman Aaron Jagdfeld sold over $1M in company shares 10/05/20 Generac acquires Enbala Power Networks, terms undisclosed GNRC Generac $265.17 / -3.54 (-1.32%) 01/20/21 JPMorgan Generac price target raised to $279 from $263 at JPMorgan 01/15/21 Stephens Generac price target raised to $330 from $260 at Stephens 12/24/20 Roth Capital Roth Capital calls Generac, Sunnova, Enphase favorite 2021 solar ideas 12/21/20 Roth Capital ITC/PTC extensions likely included in COVID relief package, says Roth Capital GNRC Generac $265.17 / -3.54 (-1.32%) 10/28/20 Generac raises 2020 revenue growth view to 10%-12% from 5%-8%, consensus $2.4B 10/28/20 Generac reports Q3 adjusted EPS $2.08, consensus $1.66 07/30/20 Generac reports Q2 adjusted EPS $1.40, consensus 89c GNRC Generac $265.17 / -3.54 (-1.32%) 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 11:00 Today Electrical Equipment/Multi-Industry 03/15/21 33rd Annual Roth Virtual Conference 02/11/21 Generac - GNRC

Events

Earnings calls, analyst events, roadshows and more

Today at 07:00

MBA Mortgage Applications: Purchase Index W/W: 1/22/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Refinance Index W/W: 1/22/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Composite Index W/W: 1/22/2021 Government Event
MPX
Today at 08:00

Marine Products - MPX Conference Calls
NDAQ
Today at 08:00

Nasdaq - NDAQ Conference Calls
NAVI
Today at 08:00

Navient - NAVI Conference Calls
TXT
Today at 08:00

Textron - TXT Conference Calls
CLS
Today at 08:00

Celestica - CLS Conference Calls
Today at 08:30

Durable Goods New Orders M/M: December 2020 Government Event
Today at 08:30

Durable Goods Orders--Ex Transportation M/M: December 2020 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $22.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CBIO X CBIO Catalyst Biosciences Spot Secondary Managers: Piper Sandler, Raymond James $5.75-6.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DZSI X DZSI DZS Spot Secondary Managers: Stifel, Needham & B. Riley Securities $14.00 - 14.50 4M Shares PLUG X PLUG Plug Power Spot Secondary Managers: Morgan Stanley $65.00-67.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSNL X PSNL Personalis Spot Secondary Managers: Morgan Stanley, BofA, Citi & Cowen $38.00 - 40.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares CALT X CALT Calliditas Therapeutics Secondary Managers: Citi, Jefferies & Stifel, Kempen & Co.,, LifeSci Capital, Carnegie $31.20 4.5M Shares DCT X DCT Duck Creek Technologies Secondary Managers: Goldman Sachs, JPMorgan & BofA $52.85 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

BioCryst receives on-time approval with 'clean' label, says Piper Sandler

TODAY'S FREE FLY STORIES

Get Full Fly Access